Peter D. Haytaian, EVP & President, DBG & Ingenio Rx at Anthem, Inc. (ANTM), sold 35,366 shares at $462.73 ($16.3M) on 2022-03-10, disclosed to the SEC on 2022-03-14.
Seasonal sale ($16.3M) by EVP & President, DBG & Ingenio Rx — this insider has traded ANTM in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $458.68 | 2,170 | $995K | 6.1% |
| 2 | $458.68 | 2,170 | $995K | 6.1% |
| 3 | $459.75 | 4,274 | $2.0M | 12.1% |
| 4 | $459.75 | 4,274 | $2.0M | 12.1% |
| 5 | $460.68 | 4,105 | $1.9M | 11.6% |
| 6 | $460.68 | 4,105 |
| $1.9M |
| 11.6% |
| 7 | $461.72 | 5,874 | $2.7M | 16.6% |
| 8 | $461.72 | 5,874 | $2.7M | 16.6% |
| 9 | $462.73 | 1,240 | $574K | 3.5% |
| 10 | $462.73 | 1,240 | $574K | 3.5% |
| 11 | $463.40 | 40 | $19K | 0.1% |
| Total | $460.70 avg | 35,366 | $16.3M | 100% |
| Filing → |
| ANTM | SELL | 2021-03-23 | $41.4M | — | Filing → |
| ANTM | SELL | 2020-12-17 | $3.6M | — | Filing → |
| ANTM | SELL | 2020-11-18 | $3.4M | — | Filing → |